- Home
- AKYA vs JYNT Comparison
AKYA vs JYNT Comparison
Compare AKYA & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKYA
- JYNT
- Stock Information
- Founded
- AKYA 2015
- JYNT 2010
- Country
- AKYA United States
- JYNT United States
- Employees
- AKYA N/A
- JYNT N/A
- Industry
- AKYA Medical Specialities
- JYNT Multi-Sector Companies
- Sector
- AKYA Industrials
- JYNT Miscellaneous
- Exchange
- AKYA Nasdaq
- JYNT Nasdaq
- Market Cap
- AKYA 152.2M
- JYNT 172.8M
- IPO Year
- AKYA 2021
- JYNT 2014
- Fundamental
- Price
- AKYA $2.05
- JYNT $11.35
- Analyst Decision
- AKYA Buy
- JYNT Strong Buy
- Analyst Count
- AKYA 7
- JYNT 2
- Target Price
- AKYA $4.40
- JYNT $17.50
- AVG Volume (30 Days)
- AKYA 375.0K
- JYNT 28.8K
- Earning Date
- AKYA 03-07-2025
- JYNT 03-13-2025
- Dividend Yield
- AKYA N/A
- JYNT N/A
- EPS Growth
- AKYA N/A
- JYNT N/A
- EPS
- AKYA N/A
- JYNT N/A
- Revenue
- AKYA $86,815,000.00
- JYNT $120,795,620.00
- Revenue This Year
- AKYA N/A
- JYNT $3.28
- Revenue Next Year
- AKYA $11.90
- JYNT N/A
- P/E Ratio
- AKYA N/A
- JYNT N/A
- Revenue Growth
- AKYA N/A
- JYNT 5.26
- 52 Week Low
- AKYA $1.88
- JYNT $9.10
- 52 Week High
- AKYA $6.31
- JYNT $17.82
- Technical
- Relative Strength Index (RSI)
- AKYA 32.17
- JYNT 52.34
- Support Level
- AKYA $2.21
- JYNT $11.29
- Resistance Level
- AKYA $2.37
- JYNT $11.98
- Average True Range (ATR)
- AKYA 0.15
- JYNT 0.33
- MACD
- AKYA -0.06
- JYNT -0.03
- Stochastic Oscillator
- AKYA 8.79
- JYNT 47.06
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.